The largest database of trusted experimental protocols
> Anatomy > Body Part > Atrium, Left

Atrium, Left

The left atrium is one of the four chambers of the heart.
It receives oxygenated blood from the lungs and pumps it into the left ventricle, which then distributes it throughout the body.
The left atrium plays a crucial role in the cardiovascular system by facilitating blood flow and maintaining proper heart function.
Its structure and function are important considerations in the diagnosis and treatment of various heart conditions.
Understaanding the left atrium's anatomy and physiologey is essentail for effective medical interventions and research.

Most cited protocols related to «Atrium, Left»

The dataset consists of short-axis and long-axis cine CMR images of 5,008 subjects (61.2 ±7.2 years, 52.5% female), acquired from the UK Biobank. The baseline characteristics of the UK Biobank cohort can be viewed in the data showcase at [16 ]. For short-axis images, the in-plane image resolution is 1.8 ×1.8 mm2 with slice thickness of 8.0 mm and slice gap of 2 mm. A short-axis image stack typically consists of 10 image slices. For long-axis images, the in-plane image resolution is 1.8 ×1.8 mm2 and only 1 image slice is acquired. Each cardiac cycle consists of 50 time frames. For both short-axis and long-axis views, the balanced steady-state free precession (bSSFP) magnitude images were used for analysis. Details of the image acquisition protocol can be found in [17 (link)].
Manual image annotation was undertaken by a team of eight observers under the guidance of three principal investigators and following a standard operating procedure [18 (link)]. For short-axis images, the LV endocardial and epicardial borders and the RV endocardial borders were manually traced at ED and ES time frames using the cvi42 software (version 5.1.1, Circle Cardiovascular Imaging Inc., Calgary, Alberta, Canada). For long-axis 2-chamber view (2Ch) images, the left atrium (LA) endocardial border was traced. For long-axis 4-chamber view (4Ch) images, the LA and the right atrium (RA) endocardial borders were traced.
In pre-processing, the CMR DICOM images were converted into NIfTI format. The manual annotations from the cvi42 software were exported as XML files and also converted into NIfTI format. The images and annotations were quality controlled to ensure that annotations cover both ED and ES frames and without missing slices or missing anatomical structures. For short-axis images, 4,875 subjects (with 93,500 annotated image slices) were available after quality control, which were randomly split into three sets of 3,975/300/600 for training/validation/test, i.e. 3,975 subjects for training the neural network, 300 validation subjects for tuning model parameters, and finally 600 test subjects for evaluating performance. For long-axis 2Ch images, 4,723 subjects were available after quality control, which were split into 3,823/300/600. For long-axis 4Ch images, 4,682 subjects were available, which were split into 3,782/300/600.
Full text: Click here
Publication 2018
Atrium, Left Atrium, Right Cardiovascular System Endocardium Epistropheus Heart Reading Frames Woman
LV end-diastolic diameter (LVEDD) was measured on the short-axis cine image of the LV at the level of the papillary muscles. LV end-diastolic volume index (LVEDVi), LV end-systolic volume index (LVESVi), LV ejection fraction (LVEF), LV cardiac output (CO), LV cardiac index (CI) and LV mass (LVM) were measured using a post-processing workstation (Philips Intellispace Portal 7.0 and Advantage Workstation 4.6). LV endocardial and epicardial contours were drawn on LV short-axis cine images (papillary muscles were excluded).
LA anteroposterior (AP) diameters were measured on transversal dark blood images. LA volume and function were analyzed using commercial post-processing software (QStrain, Medis Suite 3.1, Leiden, the Netherlands). The LA endocardial border was manually delineated using a point-and-click approach when the atrium was at its maximum and minimum volumes in both the 2-and 4-chamber cine images (pulmonary veins and LA appendage were excluded) (Fig. 1A1-B2). Then the contours were automatically propagated in all frames throughout the entire cardiac cycle (25 frames/cardiac cycle). CMR-FT was visually reviewed to ensure accurate tracking. In cases of inadequate tracking, the endocardial border was manually readjusted and then the propagation algorithm was reapplied. LA global strain and SR were calculated as the average of the two and four chamber views [20 (link)]. Tracking was blindly repeated three times in both the 2-and 4-chamber views, and the results of the LA volume, strain and SR from the three tracking repetitions were averaged in both views. Three aspects of LA strain were analyzed as previously described [19 (link)–21 (link)] (Fig. 1C): total strain (εs, corresponding to LA reservoir function), active strain (εa, corresponding to LA booster pump function) and passive strain (εe, corresponding to LA conduit function, the difference between εs and εa). Accordingly, three SR parameters were evaluated (Fig. 1D): peak positive strain rate (SRs, corresponding to LA reservoir function), peak early negative strain rate (SRe, corresponding to LA conduit function) and peak late negative strain rate (SRa, corresponding to LA booster pump function).

This figure shows a representative example of left atrial (LA) tracking on both the 2-and 4- chamber cines in a normal control subject. A1 and A2 left ventricular (LV) end-diastole and end-systole respectively on the 2-chamber view, B1and B2 LV end-diastole and end-systole respectively on the 4-chamber view. C and D The LA strain and strain rate curves. The total strain (εs), Passive strain (εe) and active strain (εa) were identified from the strain curves. The strain rates during LV systole (SRs), LV early diastole (SRe), and atrial contraction (SRa) were also determined from the strain rate curve. E LA volume curve. The LA maximum volume (Vmax), the pre-contraction volume (Vpre-a), and the minimum volume (Vmin) are shown here

LA volume (LAV) was assessed at LV end-systole (LAVmax), at LV diastole before LA contraction (LAVpre-a), and at late LV diastole after LA contraction (LAVmin) (Fig. 1E). The parameters of the LAV were obtained from a volume curve generated using Simpson’s method. From the LAV, the LA emptying fractions (LAEF) were calculated as follows: (1) LA total EF = (LAVmax-LAVmin) × 100%/LAVmax, (2) LA passive EF = (LAVmax-LAVpre-a) × 100%/LAVmax, (3) LA active EF = (LAVpre-a-LAVmin) × 100%/LAVpre-a [21 (link)].
For estimating the LA segmental function, the software automatically divided the LA wall into 6 segments on both the 2- and 4-chamber views and generated strain curves and SR for each segment. As has been previously described [10 (link)], the LA segments were described as anterior, antero-roof, inferior, septal, septal-roof and lateral walls (Fig. 2A1-B4). The values of the LA segmental strain and SR were obtained from the average of the three repeated measurements. In the case of insufficient tracking quality, the corresponding segments were excluded from the final analysis. Patients with inadequate tracking quality in more than three segments were excluded from the study.

LA segmentation in representative cases of a healthy subject (A1–4) and a NOHCM patient (B1–4). The LA wall is automatically divided into 6 segments by the software [segment1(S1): anterior, segment2(S2): antero-roof, segment3(S3): inferior, segment4(S4): septal, segment5(S5): septal-roof, segment6(S6): lateral]. Comparison of LA global strain (C) and strain rate (D), segmental strain (C1–6) and strain rate (D1–6) between the non-obstructive hypertrophic cardiomyopathy (NOHCM) (yellow line) and the control (white line), the LA global strain and strain rate in the NOHCM were similar to the control, while segmental strain (inferior) and strain rate (antero-roof, inferior, septal and septal-roof) were lower in the NOHCM than the control. The yellow X axis represented the cardiac cycle length of a patient with NOHCM, and the white X axis represented the cardiac cycle length of a healthy control. εs = total strain, εe = passive strain, ε =, active strain, SRs = peak positive strain rat, SRe = peak early negative strain rate, SRa = peak late negative strain rate. Time dependent curves of the strain parameters were plotted offline using raw values provided by software

Full text: Click here
Publication 2020
Atrial Function, Left Atrium, Left Auricular Appendage Blood Cardiac Output Diastole Endocardium Epistropheus Healthy Volunteers Heart Heart Atrium Hypertrophic Obstructive Cardiomyopathy Left Ventricles Papillary Muscles Patients Reading Frames Secondary Immunization Strains Systole Veins, Pulmonary
Mice were treated with 50ul of 1000U/ml s.c. heparin, and then euthanized with Isoflurane. The chest cavity was opened, the left atrium nicked, and the lungs perfused with 10ml of PBS through the right atrium. The trachea was then exposed, a small incision was made at its top, and an 18 gauge angiocath was inserted and secured. Lung was inflated with digestion solution containing 1.5mg/ml of Collagenase A (Roche) and 0.4mg/ml DNaseI (Roche) in HBSS plus 5% fetal bovine serum and 10mM HEPES. Trachea was tied off with 2.0 sutures. The heart and mediastinal tissues were carefully removed and the lung parenchyma placed in 5ml of digestion solution and incubated at 37°C for 30 minutes with gently vortexing every 8–10 minutes. Upon completion of digestion, 25ml of PBS was added; and the samples were vortexed at maximal speed for 30 seconds. The resulting cell suspensions were strained through a 70um cell strainer and treated with ACK RBC lysis solution.
Full text: Click here
Publication 2016
Atrium, Left Atrium, Right Cells Collagenase Digestion Fetal Bovine Serum Heart Hemoglobin, Sickle Heparin HEPES Isoflurane Lung Mediastinum Mus Neoplasm Metastasis Sutures Thoracic Cavity Tissues Trachea
All DNA methylation profiles were determined either on the Illumina Infinium Human Methylation 450K or EPIC BeadChip arrays. DNA methylation data for white blood cells (neutrophils, monocytes, B-cells, CD4+ T-cells, CD8+ T-cells, NK-cells, n = 6 each) were downloaded from GSE110555 (EPIC)38 (link). Data for erythrocyte progenitors (n = 5) were downloaded from GSE63409 (450K)39 (link), and data for left atrium (n = 4) were downloaded from GSE62727 (450K)40 (link). Data for bladder (n = 19), breast (n = 98), cervix (n = 3), colon (n = 38), esophagus (n = 16), oral cavity (n = 34), kidney (n = 160), prostate (n = 50), rectum (n = 7), stomach (n = 2), thyroid (n = 56), and uterus (n = 34) were downloaded from TCGA26 (link). DNA methylation data for adipocytes (n = 3, 450K), hepatocytes (n = 3, 450K and EPIC), alveolar lung cells (n = 3, EPIC), neurons (n = 3, 450K and EPIC), vascular endothelial cells (n = 2, EPIC) pancreatic acinar cells (n = 3, 450K and EPIC), duct cells (n = 3, 450K and EPIC), beta cells (n = 4, 450K and EPIC), colon epithelial cells (n = 3, EPIC) were generated in house and are available from the corresponding authors upon reasonable request. Detailed sample information is available in Supplementary Data 1.
Full text: Click here
Publication 2018
Acinar Cell Adipocytes Alveolar Epithelial Cells Atrium, Left B-Lymphocytes Breast CD4 Positive T Lymphocytes CD8-Positive T-Lymphocytes Cells Cervix Uteri Colon DNA Methylation Epithelial Cells Erythrocytes Esophagus Hepatocyte Homo sapiens Kidney Leukocytes Lung Methylation Monocytes Natural Killer Cells Neurons Neutrophil Oral Cavity Pancreas Pancreatic beta Cells Prostate Rectum Stomach Thyroid Gland Urinary Bladder Uterus Vascular Endothelial Cells

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Atrium, Left Body Surface Area Contracture Diastole Endocardium Heart Heart Atrium Mitral Valve Multimodal Imaging Reading Frames Strains Systole Tissues

Most recents protocols related to «Atrium, Left»

Not available on PMC !

Example 3

A cohort of patients post cardioversion are administered an effective amount of the imaging agent of the invention, images of each patient's left atrium are obtained and the uptake of the imaging agent is quantified. A cut point for imaging agent uptake is then established such that the cut point separates the cohort into 2 populations; those above the cut point have recurrent AF while those below the cut point do not.

Based on the cut point levels determined above, future patients are then tested for MMP levels using the methods of the invention and those demonstrating above cut point levels are treated using one or more of the therapies described herein and known in the art for AF, including but not limited to pharmacological rate control therapy, pharmacological rhythm control therapy, ablation, and/or implantable pacer.

Full text: Click here
Patent 2024
Atrial Fibrillation Atrium, Left Electric Countershock Matrix Metalloproteinase 3 Patients Population Group
Not available on PMC !

Example 4

A cohort of patients with a recent history of myocardial infarction are administered an effective amount of the imaging agent of the invention, images of each patient's left atrium are obtained and the uptake of the imaging agent is quantified. The patients also undergo a resting flurpiridaz F 18 myocardial perfusion study and the summed rest score determined for each patient. Logisitic regression analysis is performed to produce an equation expressing the likelihood of future AF as a function of summed rest score and quantified imaging agent uptake.

Full text: Click here
Patent 2024
Atrial Fibrillation Atrium, Left Matrix Metalloproteinases Myocardial Infarction Myocardium Patients Perfusion
Consecutive patients with paroxysmal AF who had been hospitalized in Henan Provincial People’s Hospital for diagnosis and treatment between January 2018 and December 2019 were retrospectively reviewed. Reports from transthoracic echocardiograms that were performed before catheter ablation of AF were screened. MR was defined as functional if leaflets showed normal morphology but did not properly coapt because of either left ventricular (LV) or left atrial (LA) dilatation.[10 (link)] The severity of functional MR was graded as mild, moderate, or severe.[10 (link)] Moderate or severe MR was considered clinically significant in the present study. The inclusion criteria were as follows: age < 80 years; LA diameter < 55 mm; and LV ejection fraction ≥ 35%. The exclusion criteria were as follows: previous AF ablation; previous cardiac surgery or congenital heart disease; and primary MR (mitral valve prolapse, rheumatic disease, endocarditis, previous papillary muscle rupture, or abnormalities in mitral valve leaflets or chordae). The study complied with the Declaration of Helsinki and the study protocol was approved by the Research and Development Department at Central China Fuwai Hospital.
Publication 2023
Atrium, Left Catheter Ablation Congenital Abnormality Congenital Heart Defects Diagnosis Dilatation Echocardiography Endocarditis Fibrillation, Paroxysmal Atrial Left Ventricles Mitral Valve Mitral Valve Prolapse Syndrome Papillary Muscles Patients Rheumatism Surgical Procedure, Cardiac Ventricular Ejection Fraction
This was a cross-sectional study as well as a part of the Baduanjin-Eight-Silken-Movement with Self-efficacy Building for Patients with Chronic Heart Failure (BESMILE-HF) trial (NCT03180320, ClinicalTrials.gov, registration date: 08/06/2017) [6 (link)]. Patients with CHF were prospectively recruited between February 2019 and July 2022 if they fulfilled the following inclusion criteria: (1) ≥ 18 years of age; (2) met the diagnostic criteria for CHF [7 (link)]; (3) clinically stable, defined as symptoms/signs that remained generally unchanged for ≥ 1 month; (4) New York Heart Association class II or III; (5) used beta-blockers; and (6) provided informed consent [8 (link)].
The exclusion criteria were as follows: (1) patients with contraindications for exercise testing, namely, early phase after acute coronary syndrome (up to 6 weeks), life-threatening cardiac arrhythmias, acute heart failure (during the initial period of hemodynamic instability), uncontrolled hypertension (systolic blood pressure > 200 mmHg and/or diastolic blood pressure > 110 mmHg), advanced atrioventricular block, acute myocarditis and pericarditis, moderate to severe aortic valve/mitral stenosis, severe aortic valve/mitral regurgitation, severe hypertrophic obstructive cardiomyopathy, acute systemic illness, or intracardiac thrombus; (2) patients with serious acute or chronic diseases affecting major organs or with mental disorders; (3) patients with a history of cardiac surgery, cardiac resynchronization therapy, intracardiac defibrillation, or implantation of a combined device within the previous 3 months; (4) patients with a history of cardiac arrest within 1 year; (5) patients with a history of peripartum cardiomyopathy, hyperthyroid heart disease, or primary pulmonary hypertension; and (6) patients unable to perform a recumbent bicycle stress test (Fig. 1) [6 (link)].

Flow chart of this study

Eligible participants underwent clinical evaluation (including history of cardiac risk factors and medications), height and weight measurements, blood testing, and electrocardiography. They then underwent a cardiopulmonary exercise test (CPET) and transthoracic echocardiography assessment at rest on the same day (Fig. 2A, B). The BESMILE-HF study[6 (link)] was approved by the Ethics Committee of the Guangdong Provincial Hospital of Chinese Medicine (Approval No. B2016-202-01). All of the participants provided written informed consent.

Illustration of speckle-tracking echocardiography examination (A) and cardiopulmonary exercise testing (B). Strain analysis of the left atrium in the locally enlarged apical four-chamber view and the LA strain curve throughout the cardiac cycle (C). The curves of VO2 and VCO2 with time and work rate, respectively (D). LA, left atrial; VO2, oxygen uptake; VCO2, carbon dioxide uptake; VO2max/pre, ratio of maximum to predicted oxygen uptake, WR, work rate

Full text: Click here
Publication 2023
Acute Coronary Syndrome Adrenergic beta-Antagonists Aortic Valve Insufficiency Aortic Valve Stenosis Atrioventricular Block Atrium, Left Carbon dioxide Cardiac Arrest Cardiac Arrhythmia Cardiac Resynchronization Therapy Cardiomyopathies Chinese Diagnosis Disease, Chronic Echocardiography Electric Countershock Electrocardiography Ethics Committees, Clinical Exercise Tests Heart Heart Diseases Heart Failure Hemodynamics High Blood Pressures Hyperthyroidism Hypertrophic Obstructive Cardiomyopathy Idiopathic Pulmonary Arterial Hypertension Medical Devices Mental Disorders Movement Myocarditis Ovum Implantation Oxygen Patients Pericarditis Pharmaceutical Preparations Pressure, Diastolic Signs and Symptoms Silk Strains Surgical Procedure, Cardiac Systolic Pressure Thrombus
All images were analyzed by a single investigator (S.C.) who was blinded to the participants’ characteristics and exercise performance. For the LA strain, the LA endocardium was manually traced at the end systole stage of LV, and the software automatically tracked the myocardium throughout the cardiac cycle on electrocardiography using R-to-R gating. Figure 2C shows the LA strain curve throughout the cardiac cycle. The region of interest was adjusted to the smallest LA wall thickness for tracking. The LA strain is the average value measured in the 4- and 2-apical chamber views. In the reservoir phase, as the left atrium filled and stretched, there was a positive atrial strain that peaked in systole at the end of LA filling and before the opening of the mitral valve; this was the LA reservoir strain, which was defined as the difference between the nadir and the peak of the strain curve. Elevated LAVI was defined as LAVImax ≥ 34 mL/m2, while reduced LA reservoir strain was defined as LA reservoir strain < 23% [4 (link), 14 (link)]. Subsequent passive LA emptying with the opening of the mitral valve was observed, with negative deflection of the strain curve until a plateau was reached; this was the LA conduit strain, which was defined as the difference between the peak of the strain curve and the onset of atrial contraction following the P wave. Then, a second negative deflection in the strain curve was observed corresponding to atrial systole, which represented LA active contraction. The LA booster strain was defined as the difference between the onset of atrial contraction and the nadir of the strain curve [13 (link), 14 (link)] (Fig. 2C).
The LV endocardium was traced at end systole in the 4-, 3-, and 2- apical views; the region of interest was selected with software and was adjusted to accommodate the thickness of the LV myocardium. The LV global longitudinal strain (LVGLS) was measured as the average strain of 17 segments.
Full text: Click here
Publication 2023
Atrium, Left Electrocardiography Endocardium Heart Heart Atrium Mitral Valve Myocardium Secondary Immunization Strains Systole

Top products related to «Atrium, Left»

Sourced in United States, Norway, United Kingdom, Japan, France, Canada, Germany, Belgium
The Vivid 7 is a high-performance ultrasound system designed for cardiovascular and general imaging applications. It features advanced imaging technologies and versatile capabilities to support comprehensive diagnostic assessments.
Sourced in United States, Norway, Japan, United Kingdom, Germany
The Vivid E9 is a diagnostic ultrasound system developed by GE Healthcare. It is designed to provide high-quality imaging for a wide range of clinical applications.
Sourced in United States
PentaRay is a versatile lab equipment designed to perform a variety of tasks. It features five distinct components that can be used individually or in combination, allowing for increased efficiency and flexibility in laboratory operations. The core function of PentaRay is to facilitate various experimental and analytical procedures required in research and development settings.
Sourced in United States, Netherlands, Germany, Norway, United Kingdom
The EPIQ 7 is a high-performance ultrasound imaging system designed for a wide range of clinical applications. It features advanced imaging technologies and a user-friendly interface to provide clear and detailed images for diagnosis and treatment planning.
Sourced in United States, Sao Tome and Principe
CARTO 3 is a medical device designed for advanced cardiac mapping and visualization. It provides healthcare professionals with a platform to generate and analyze detailed 3D maps of the heart's electrical activity.
Sourced in Canada, United States, Japan
The Vevo 2100 is a high-resolution, real-time in vivo imaging system designed for preclinical research. It utilizes advanced ultrasound technology to capture detailed images and data of small animal subjects.
Sourced in United States, Japan
Thermocool is a laboratory equipment designed for precise temperature control and monitoring. It is used to maintain and regulate temperatures in various laboratory applications.
Sourced in United States, Germany, Japan, Netherlands, Norway
The Sonos 5500 is a laboratory equipment designed for ultrasound imaging and analysis. It features a high-resolution display and advanced signal processing capabilities. The device is capable of generating and receiving ultrasound signals for a variety of applications in research and diagnostic settings.
Sourced in United States
The CARTO 3 system is a laboratory equipment product designed for three-dimensional mapping and visualization of cardiac electrical activity. It provides real-time data capture and display capabilities to support cardiac diagnostic and treatment procedures.
Sourced in United States, Norway, United Kingdom, Japan
The Vivid E95 is a high-performance cardiovascular ultrasound system designed for comprehensive cardiac and vascular imaging. It features advanced technologies and a user-friendly interface.

More about "Atrium, Left"

The left atrium is a crucial component of the cardiovascular system, responsible for receiving oxygenated blood from the lungs and pumping it into the left ventricle.
This four-chambered heart structure plays a vital role in maintaining proper heart function and blood flow throughout the body.
Understanding the anatomy and physiology of the left atrium is essential for effective medical interventions and research.
Synonyms for the left atrium include the 'upper left chamber of the heart' and the 'LA'.
Related terms include the 'right atrium', 'left ventricle', and 'right ventricle' - the four chambers that make up the heart.
Abbreviations commonly used include 'LA' for left atrium.
Key subtopics related to the left atrium include its structure, function, and role in various heart conditions.
The left atrium's structure is typically examined using echocardiographic imaging techniques like Vivid 7, Vivid E9, and EPIQ 7.
The CARTO 3 system and Thermocool catheters may be used to map and treat electrical activity in the left atrium.
The Vevo 2100 and Sonos 5500 imaging systems can also provide detailed visualizations of the left atrium's anatomy and function.
Understanding the left atrium's role in conditions like atrial fibrillation, mitral valve disease, and heart failure is crucial for effective diagnosis and treatment.
The Vivid E95 echocardiography system, for example, can be used to assess left atrial size and function, which are important markers for these heart conditions.
By incorporating the latest medical imaging and mapping technologies, clinicians and researchers can gain deeper insights into the left atrium's structure and function, ultimately leading to better patient outcomes.